Eye mounted device for therapeutic agent release
US-12167978-B2 · Dec 17, 2024 · US
Porous photonic crystals for drug delivery to the eye
US8945602B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8945602-B2 |
| Application number | US-201313854039-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 29, 2013 |
| Priority date | Oct 29, 2004 |
| Publication date | Feb 3, 2015 |
| Grant date | Feb 3, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
A minimally invasive controlled drug delivery system for delivering a particular drug or drugs to a particular location of the eye, the system including a porous film template having pores configured and dimensioned to at least partially receive at least one drug therein, and wherein the template is dimensioned to be delivered into or onto the eye.
First claim
Opening claim text (preview).
What is claimed is: 1. A method for treating an intraocular disease of the eye comprising administering to an eye of a patient a porous silicon dioxide particle having pores comprising a drug for treatment of the disease, thereby delivering the drug to the eye. 2. The method of claim 1 , wherein the porous silicon dioxide particle has a dimension of from 1 μm to 270 μm. 3. The method of claim 1 , wherein the porous silicon dioxide particle…
Assignees
Inventors
Classifications
- A61F9/0017Primary
Human Necessities · mapped topic
Human Necessities · mapped topic
- A61K9/0048Primary
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8945602B2 cover?
- A minimally invasive controlled drug delivery system for delivering a particular drug or drugs to a particular location of the eye, the system including a porous film template having pores configured and dimensioned to at least partially receive at least one drug therein, and wherein the template is dimensioned to be delivered into or onto the eye.
- Who is the assignee on this patent?
- Univ California
- What technology area does this patent fall under?
- Primary CPC classification A61F9/0017. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).